1. Home
  2. Analysis
  3. Isoniazid
  4. Dermatitis-atopic

Isoniazid and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Isoniazid (isoniazid), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Folic Acid, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Isoniazid. It is created by eHealthMe based on reports of 19,852 people who have side effects when taking Isoniazid from the FDA, and is updated regularly.

What is Isoniazid?

Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,969 drugs and 1,975 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

19,852 people reported to have side effects when taking Isoniazid.
Among them, 29 people (0.15%) have Dermatitis - atopic.

Could Isoniazid cause Dermatitis - atopic?

Among these 29 people:

How long have people been on Isoniazid when they have Dermatitis - atopic? *

  • < 1 month: 30 %
  • 1 - 6 months: 70 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Dermatitis - atopic when taking Isoniazid? *

  • female: 51.72 %
  • male: 48.28 %

What is the age of people who have Dermatitis - atopic when taking Isoniazid? *

  • 0-1: 3.85 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.54 %
  • 30-39: 15.38 %
  • 40-49: 3.85 %
  • 50-59: 11.54 %
  • 60+: 53.85 %

What are other drugs people take besides Isoniazid? *

  1. Folic Acid: 5 people, 17.24%
  2. Humira: 4 people, 13.79%
  3. Prednisolone: 3 people, 10.34%
  4. Arava: 3 people, 10.34%
  5. Pyrazinamide: 3 people, 10.34%
  6. Calcium: 3 people, 10.34%
  7. Diovan: 3 people, 10.34%
  8. Doxazosin Mesylate: 3 people, 10.34%
  9. Rifampin: 3 people, 10.34%
  10. Etodolac: 3 people, 10.34%

What are other side effects people have besides Dermatitis - atopic? *

  1. Rashes (redness): 8 people, 27.59%
  2. Diarrhea: 8 people, 27.59%
  3. Itching: 8 people, 27.59%
  4. Hair Loss: 7 people, 24.14%
  5. Stress And Anxiety: 5 people, 17.24%
  6. Rash Pustular (redness with pustules): 5 people, 17.24%
  7. Psoriasis (immune-mediated disease that affects the skin): 5 people, 17.24%
  8. Dizziness: 5 people, 17.24%
  9. Nausea (feeling of having an urge to vomit): 5 people, 17.24%
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 4 people, 13.79%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 27.59%
  2. Psoriasis (immune-mediated disease that affects the skin): 4 people, 13.79%
  3. Tuberculosis Gastrointestinal (a bacterial infection of digestive tract by mycobacterium tuberculosis): 2 people, 6.90%
  4. Pneumonia: 2 people, 6.90%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 6.90%
  6. Lymph Node Tuberculosis: 2 people, 6.90%
  7. Latent Tuberculosis (hidden tuberculosis): 2 people, 6.90%
  8. Insomnia (sleeplessness): 2 people, 6.90%
  9. Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 6.90%
  10. Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Isoniazid and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isoniazid:

Dermatitis - atopic treatments and more:

How severe was Dermatitis - atopic and when was it recovered:

Expand to all the drugs that have ingredients of isoniazid:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Browse all the conditions that are associated with Dermatitis - atopic:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on isoniazid (the active ingredients of Isoniazid) and Isoniazid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.